Table 6.
FUNCTIONS | GENE SYMBOLS |
---|---|
Inflammation, inflammatory response | RELB, KITLG, LAP (C/EBP), OSMR, THBD, PTX3, CCL20, CCL25,HMGB1, CXCL12, IL16, PRSS23, F2RL1, PLA2G4A, LP-PLA2 |
Platelet activation | GP1BA,PLA2G4A, FGA, F2R |
Chemotaxis, chemo-attraction, adhesion, | CCL20, CCL25,CCL2, DOCK2, CXCL12, IL16,THBS1 |
Hyperlipidemia | PTGS2, TXNIP, VLDRLCH |
Atherosclerotic lesion including fibrosis, growth, thrombosis | PTX3, PTGS2, ERN1,SERPINB8, HRG1, GP1BA, VLDLRCH, THBD,P2RY1,TFPI-2, FGA,, FN1, F2R, F2RL1, PLAT, ACAT2, CCL2, PDE4A, CD59, KPTN, PLA2G4A, LP-PLA2,PLG, THBS1, ANGPT2, PROC |
Myocardial ischemia, heart failure | AMY2B, DUSP6, PTGS2, ADRA1B, IGF2R, MDM2, HTT, MYH7, PDE4A, BIRC5, APLN, CTGF, E2F1, NPR3PLG, |
Ischemia, ischemic cardiomyopathy | DDIT3, PTGS2, ADORA2B, CXCL3, GP1BA, PPP1R15, NPR3, CXCL12, ENG, HMGB1, PARP1, F2R,PLG, |
Myocardial infarction, infarct | CD55, ADORA2B, ADRA1B, IL1A, IRF1, NAMPT, PMAIP1, THBD, CAPN5, PTGS2BAT1, HMGB1, COL3A1, CXCL12, ACTA1, PLG, |
Tachycardia, arrhythmia, atrial fibrillation | CHRNA7, CHRNE, KITLG, PTGS2, TAC1, ADORA2B, ADRA1B, UCN, KCNMA1,VCL, HMGB1 |
Pericarditis | TUBA1A, TUBA4B, TUBB3, TUBB2C, TUBE1 |
Dilation of heart | CCNA2, LMNA, PTGES, F2R |
Cardiac damage, injury | ANXA1, ATF4, HMOX1,APLN |
Cardiac necrosis/cell death | MDM2, NAMPT, TXNIP, UCN, GABRD,PARP1, TNFAIP3, BCL2L11, BIRC5, E2F1, FSTL1, ZYX, NRG |
Cardiac hypertrophy | ATF3, ADAM17, PTGS2, DUSP1, HDAC9, FBXO32, IER3, MDM2, HMOX1, FABP3,SMTN, BIRC5, CXCL12, PBX1, PLA2G4A, F2R, CTSC, H2AFZ, IL33, NFATC4, PTGES, RGS4, S100A10, TNFAIP3, APLN, DES, MYH7, ANGPT2 |
Hyperplasia, regeneration | CCNA2, HMGB1 |
Stroke | FABP3, PTGS2, RRM2, SPATA13 |
Up-regulated genes are shown in bold and down-regulated genes are shown in italics. The expression pattern of the underlined genes PLG, THBS1, ANGPT2 and PROC was dependent on either the specific drug or the cell type.